United Capital Management of KS Inc. Has $18.89 Million Stake in SPDR S&P Biotech ETF $XBI

United Capital Management of KS Inc. increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 188,529 shares of the exchange traded fund’s stock after buying an additional 4,182 shares during the period. SPDR S&P Biotech ETF accounts for about 2.6% of United Capital Management of KS Inc.’s investment portfolio, making the stock its 8th biggest position. United Capital Management of KS Inc. owned about 0.31% of SPDR S&P Biotech ETF worth $18,891,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in XBI. Capital A Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $26,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $31,000. Twin Peaks Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at $32,000. Davis Capital Management bought a new stake in SPDR S&P Biotech ETF in the third quarter worth $35,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the third quarter valued at $40,000.

SPDR S&P Biotech ETF Stock Down 2.0%

XBI stock opened at $123.90 on Friday. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09. The firm has a market capitalization of $8.28 billion, a P/E ratio of 11.47 and a beta of 0.93. The company has a fifty day simple moving average of $125.19 and a two-hundred day simple moving average of $113.54.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.